XML 74 R18.htm IDEA: XBRL DOCUMENT

Insider Trading Arrangements

3 Months Ended

6 Months Ended

Jun. 30, 2024

From time to time, our officers (as defined in Rule 16a–1(f)) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the

three months ended June 30, 2024, our officers and directors took the following actions with respect to such trading arrangements:

Action

Date

Trading Arrangement

Total Shares to be Sold

Expiration Date

Rule 10b5-1*

Non-Rule 10b5-1**

Michael MacLean (Chief Financial and Chief Business Officer)

Adopt

4/2/2024

124,423

6/30/2025

W. Michael Flanagan (Chief Scientific and Technical Officer)

Adopt

6/12/2024

271,958(1)

6/12/2026

Teresa McCarthy (Chief Human Resources Officer)

Adopt

6/12/2024

200,000

12/31/2025

____________________

* Intended to satisfy the affirmative defense of Rule 10b5-1(c)

** Not intended to satisfy the affirmative defense of Rule 10b5-1(c)

(1)Subject to increase based on a future award of our common stock covered by this 10b5-1 plan, the number of such securities is not able to be determined as of the date hereof.

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Michael MacLean [Member]

Trading Arrangements, by Individual

Name

Michael MacLean

Title

(Chief Financial and Chief Business Officer)